@article{43f6f3511c1847d182d5b98fad66404f,
title = "Novel Noninvasive Biosensors and Artificial Intelligence for Optimized Heart Failure Management",
author = "Luke Neill and Mozziyar Etemadi and Liviu Klein and Inan, {Omer T.}",
note = "Funding Information: Dr Neill has an equity stake in Cardiosense, Inc; and is an employee of Cardiosense. Dr Etemadi is a cofounder, board member, and advisor for Cardiosense, Inc; and has an equity stake in Cardiosense. Dr Inan is a scientific advisor for Physiowave, Inc; a cofounder, board member, and scientific advisor for Cardiosense, Inc; has an equity stake in Cardiosense; is a cofounder, board member, and scientific advisor for Arthroba, Inc; has an equity stake in Arthroba, Inc; has received research funding for his lab from Hillrom, Inc and Cisco, Inc; and has intellectual property licensed by Physiowave, TandemLaunch, and Cardiosense. Dr Klein has an equity stake in Cardiosense, Inc; and is a clinical advisor for Cardiosense.",
year = "2022",
month = mar,
doi = "10.1016/j.jacbts.2022.02.014",
language = "English (US)",
volume = "7",
pages = "316--318",
journal = "JACC: Basic to Translational Science",
issn = "2452-302X",
publisher = "Elsevier Inc.",
number = "3P2",
}